ArticlePLoS biology2026
DRfold2 is a deep learning-based tool that enables efficient and accurate RNA structure prediction.
Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Folding the message: mRNA structure as a regulatory layer of human mitochondrial gene expression.Biochimica et biophysica acta. Molecular cell research · 2026Review
- RNAbpFlow: base pair-augmented SE(3) flow matching for conditional RNA 3D structure generation.Nature methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA structures are essential for understanding their biological functions and developing RNA-targeted therapeutics. However, accurate RNA structure prediction from sequence remains a crucial challenge. We introduce DRfold2, a deep learning framework that integrates a novel pre-trained RNA Composite Language Model (RCLM) with a denoising structure module for end-to-end RNA structure prediction. Based solely on single sequence, DRfold2 achieves superior performance in both global topology and secondary structure predictions over other state-of-the-art approaches across multiple benchmark tests from diverse species. Detailed analyses reveal that the improvements primarily stem from the RCLM's ability to capture co-evolutionary pattern and the effective denoising process, with a more than 100% increase in contact prediction precision compared to existing methods. Furthermore, DRfold2 demonstrates high complementarity with AlphaFold3, achieving statistically significant accuracy gains when integrated into our optimization framework. By uniquely combining composite language modeling, denoising-based end-to-end learning, and deep learning-guided post-optimization, DRfold2 establishes a distinct direction for advancing ab initio RNA structure prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.